These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21496280)

  • 1. Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer.
    Umekita Y; Ohi Y; Souda M; Rai Y; Sagara Y; Sagara Y; Tamada S; Tanimoto A
    Diagn Pathol; 2011 Apr; 6():36. PubMed ID: 21496280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
    Nassar A; Sussman ZM; Lawson D; Cohen C
    Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers.
    Sung H; Garcia-Closas M; Chang-Claude J; Blows FM; Ali HR; Figueroa J; Nevanlinna H; Fagerholm R; Heikkilä P; Blomqvist C; Giles GG; Milne RL; Southey MC; McLean C; Mannermaa A; Kosma VM; Kataja V; Sironen R; Couch FJ; Olson JE; Hallberg E; Olswold C; Cox A; Cross SS; Kraft P; Tamimi RM; Eliassen AH; Schmidt MK; Bolla MK; Wang Q; Easton D; Howat WJ; Coulson P; Pharoah PD; Sherman ME; Yang XR
    Br J Cancer; 2016 Feb; 114(3):298-304. PubMed ID: 26679376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast].
    Niu F; Wang L; Zhang W; Lyu S; Niu Y
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):749-52. PubMed ID: 26813593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Roles of immunohistochemistry in prognostic assessment of basal-like breast cancer].
    Liu H; Fan QH; Zhang ZH; Li X; Yu HP; Liu GZ; Meng FQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):23-8. PubMed ID: 19489221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal markers and prognosis in luminal breast cancer.
    Engstrøm MJ; Valla M; Bofin AM
    Breast Cancer Res Treat; 2017 Jun; 163(2):207-217. PubMed ID: 28258354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathologic study of centrally necrotizing carcinoma of breast].
    Yu L; Yang WT; Cai X; Lu HF; Fan YZ; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):657-62. PubMed ID: 20078968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of CK5/6 and CK17 and its correlation with prognosis of triple-negative breast cancer patients].
    Liu ZB; Wu J; Ping B; Feng LQ; Shen ZZ; Shao ZM
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):610-4. PubMed ID: 19102940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.
    Guler G; Huebner K; Himmetoglu C; Jimenez RE; Costinean S; Volinia S; Pilarski RT; Hayran M; Shapiro CL
    Cancer; 2009 Feb; 115(4):899-908. PubMed ID: 19130459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of breast carcinomas classified by biomarkers and correlation with microvessel density and VEGF expression: a study from Thailand.
    Chuangsuwanich T; Pongpruttipan T; O-Charoenrat P; Komoltri C; Watcharahirun S; Sa-Nguanraksa D
    Asian Pac J Cancer Prev; 2014; 15(3):1187-92. PubMed ID: 24606439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and Functional Characterization of Ductal Carcinoma In Situ-Associated Myoepithelial Cells.
    Rohilla M; Bal A; Singh G; Joshi K
    Clin Breast Cancer; 2015 Oct; 15(5):335-42. PubMed ID: 25700939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers.
    Leibl S; Gogg-Kammerer M; Sommersacher A; Denk H; Moinfar F
    Am J Surg Pathol; 2005 Mar; 29(3):347-53. PubMed ID: 15725803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of cytokeratins 5/6 and cytokeratin 17 in invasive breast carcinoma].
    Ivković-Kapicl T; Panjković M; Nikolić I; Djilas-Ivanović D; Knezević-Usaj S
    Vojnosanit Pregl; 2012 Dec; 69(12):1031-8. PubMed ID: 23424955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers.
    Witkiewicz AK; Dasgupta A; Sammons S; Er O; Potoczek MB; Guiles F; Sotgia F; Brody JR; Mitchell EP; Lisanti MP
    Cancer Biol Ther; 2010 Jul; 10(2):135-43. PubMed ID: 20431349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of maspin is up-regulated during the progression of mammary ductal carcinoma.
    Umekita Y; Yoshida H
    Histopathology; 2003 Jun; 42(6):541-5. PubMed ID: 12786889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation.
    Leibl S; Moinfar F
    Am J Surg Pathol; 2006 Apr; 30(4):450-6. PubMed ID: 16625090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of ER, PR, HER-2, CK 5/6, p63 and EGFR antigen expression in medullary breast cancer.
    Matkovic B; Juretic A; Separovic V; Novosel I; Separovic R; Gamulin M; Kruslin B
    Tumori; 2008; 94(6):838-44. PubMed ID: 19267102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features of molecular subtypes of triple negative breast cancer based on immunohistochemical markers.
    Choi J; Jung WH; Koo JS
    Histol Histopathol; 2012 Nov; 27(11):1481-93. PubMed ID: 23018247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unique luminal staining pattern of cytokeratin 5/6 in adenoid cystic carcinoma of the breast may aid in differentiating it from its mimickers.
    Nakai T; Ichihara S; Kada A; Ito N; Moritani S; Kawasaki T; Uchiyama T; Itami H; Morita K; Takano M; Takeda M; Hatakeyama K; Ohbayashi C
    Virchows Arch; 2016 Aug; 469(2):213-22. PubMed ID: 27240462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.